Table 3.
Patients’ doses during CTA procedures.
| Procedure | CTDIvol (mGy) | DLP (mGy·cm) | Effective dose (mSv) |
|---|---|---|---|
| Cerebral | 70.8 ± 4 (60.2–80.0) |
1082.9 ± 290 (809.0–1272.8) |
2.3 ± 0.6 (1.7–2.7) |
| Chest | 30.5 ± 13 (20.0–42.0) |
581.8 ± 175 (307.0–828.4) |
8.1 ± 2.6 (4.3–11.6) |
| Abdomen | 37.7 ± 16 (18.0–40.0) |
516.0 ± 228 (446.0–749.0) |
7.4 ± 3.4 (6.7–11.2) |
| Pelvis | 27.2 ± 10.0 (11.1–34.5) |
568.8 ± 194 (405.0–709.0) |
8.9 ± 3 (6.1–10.6) |
| Lower limbs | 14.7 ± 8 (7.0–25.0) |
437.8 ± 166 (357.0–884.0) |
3.9 ± 1.4 (3.2–8.0) |